Randomized Controlled Trial of Surgical Rib Fixation to Nonoperative Management in Severe Chest Wall Injury

Area of Science:

• Trauma Surgery
• Thoracic Surgery
• Critical Care Medicine

Background:

• Surgical stabilization of rib fractures (SSRF) is known to improve outcomes in patients with flail chest and respiratory failure.
• The effectiveness of SSRF in severe chest wall injuries without clinical flail chest remains unclear.

Purpose of the Study:

• To compare the effectiveness of SSRF versus nonoperative management in severe chest wall injuries.
• To evaluate the impact of SSRF on hospital length of stay, ICU length of stay, ventilator days, opioid use, mortality, and quality of life.

Main Methods:

• A randomized controlled trial involving 84 patients with severe chest wall injury.
• Patients were randomized to either SSRF or nonoperative management.
• Primary outcome was hospital length of stay; secondary outcomes included ICU length of stay, ventilator days, opioid exposure, mortality, and quality of life scores.

Main Results:

• Hospital length of stay was significantly greater in the SSRF group (RR: 1.48).
• Intensive care unit length of stay and ventilator days were similar between groups.
• At one month, SSRF patients reported greater impairment in mobility and self-care.

Conclusions:

• SSRF did not provide a quality of life benefit for patients with severe chest wall injuries up to six months.
• SSRF increased hospital length of stay without improving other key outcomes.
• Nonoperative management may be preferred for severe chest wall injuries without clinical flail chest.